Basler Kantonalbank Share Price

Certificat

BROBKB

CH1261618800

Real-time Bid/Ask 08:17:20 02/07/2024 BST
100.51 USD / 101.32 USD -0.57% Intraday chart for Basler Kantonalbank
1 month-1.70%
3 months-1.58%
Date Price Change
01/07/24 101.5 -0.26%
28/06/24 101.8 -0.11%

Delayed Quote Swiss Exchange

Last update July 01, 2024 at 04:20 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying JOHNSON & JOHNSON
Issuer Basler Kantonalbank
BROBKB
ISINCH1261618800
Date issued 28/02/2024
Strike 161.6 $
Maturity 28/08/2025 (423 Days)
Parity 0.16 : 1
Emission price 100 $
Emission volume N/A
Settlement both
Currency USD

Technical Indicators

Highest since issue 107.1 $
Lowest since issue 100.4 $
Spread 8.1 $
Spread %0.80%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
146.4 USD
Average target price
171.7 USD
Spread / Average Target
+17.26%
Consensus
  1. Stock Market
  2. Certificates
  3. BROBKB Certificat